Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$0.11 - $0.52 $12 - $57
110 Added 0.69%
15,984 $3,000
Q4 2022

Feb 14, 2023

SELL
$0.22 - $0.51 $371 - $861
-1,690 Reduced 9.62%
15,874 $5,000
Q3 2022

Nov 10, 2022

BUY
$0.08 - $1.34 $110 - $1,843
1,376 Added 8.5%
17,564 $19,000
Q2 2022

Aug 11, 2022

BUY
N/A
16,188 New
16,188 $25,000

Others Institutions Holding GLS

# of Institutions
1
Shares Held
4.7K
Call Options Held
0
Put Options Held
0

About GELESIS HOLDINGS, INC.


  • Ticker GLS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,946,704
  • Market Cap $1.46M
  • Description
  • Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...
More about GLS
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.